These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 6491898)

  • 1. A physiologically based pharmacokinetic model for theophylline disposition in the pregnant and nonpregnant rat.
    Gabrielsson JL; Paalzow LK; Nordström L
    J Pharmacokinet Biopharm; 1984 Apr; 12(2):149-65. PubMed ID: 6491898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolism and distribution of labeled theophylline in the pregnant rat. Impairment of theophylline metabolism by pregnancy and absence of a blood-brain barrier in the fetus.
    Arnaud MJ; Bracco I; Welsch C
    Pediatr Res; 1982 Mar; 16(3):167-71. PubMed ID: 7063271
    [No Abstract]   [Full Text] [Related]  

  • 3. Analysis of pethidine disposition in the pregnant rat by means of a physiological flow model.
    Gabrielsson JL; Johansson P; Bondesson U; Karlsson M; Paalzow LK
    J Pharmacokinet Biopharm; 1986 Aug; 14(4):381-95. PubMed ID: 3772739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a Novel Maternal-Fetal Physiologically Based Pharmacokinetic Model II: Verification of the model for passive placental permeability drugs.
    Zhang Z; Unadkat JD
    Drug Metab Dispos; 2017 Aug; 45(8):939-946. PubMed ID: 28049636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of theophylline on fetal rat lung phosphatidylcholine synthesis in vivo.
    Moya FR; Gross I
    Dev Pharmacol Ther; 1985; 8(1):9-16. PubMed ID: 3987490
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A physiological pharmacokinetic model for morphine disposition in the pregnant rat.
    Gabrielsson JL; Paalzow LK
    J Pharmacokinet Biopharm; 1983 Apr; 11(2):147-63. PubMed ID: 6886971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Theophylline elimination in the pregnant and fetal rabbit.
    Brashear RE; Veng-Pedersen P; Rhodes ML; Smith CN
    J Lab Clin Med; 1982 Jul; 100(1):15-25. PubMed ID: 7086267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Theophylline pharmacokinetics in pregnant and lactating rats.
    Brandstetter Y; Kaplanski J; van Creveld C; Ben-Zvi Z
    Res Commun Chem Pathol Pharmacol; 1986 Aug; 53(2):269-72. PubMed ID: 3764089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction of drug disposition in infants and children by means of physiologically based pharmacokinetic (PBPK) modelling: theophylline and midazolam as model drugs.
    Björkman S
    Br J Clin Pharmacol; 2005 Jun; 59(6):691-704. PubMed ID: 15948934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Physiologically based pharmacokinetic modeling of the pregnant rat: a multiroute exposure model for trichloroethylene and its metabolite, trichloroacetic acid.
    Fisher JW; Whittaker TA; Taylor DH; Clewell HJ; Andersen ME
    Toxicol Appl Pharmacol; 1989 Jul; 99(3):395-414. PubMed ID: 2749729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of a physiologically based pharmacokinetic model to describe the disposition of methanol in pregnant rats and mice.
    Ward KW; Blumenthal GM; Welsch F; Pollack GM
    Toxicol Appl Pharmacol; 1997 Aug; 145(2):311-22. PubMed ID: 9266804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Theophylline neurotoxicity in pregnant rats.
    Ramzan I; DeDonato V
    Life Sci; 1988; 42(5):491-5. PubMed ID: 3339945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of maternal caffeine ingestion on the perinatal cerebrum.
    Tanaka H; Nakazawa K; Arima M
    Biol Neonate; 1987; 51(6):332-9. PubMed ID: 3607108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Maternal-fetal pharmacokinetics of methanol.
    Pollack GM; Brouwer KL
    Res Rep Health Eff Inst; 1996 Jun; (74):1-48; discussion 49-53. PubMed ID: 11381741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of imipramine and its major metabolites in pregnant rats and their fetuses following a single dose.
    DeVane CL; Simpkins JW
    Drug Metab Dispos; 1985; 13(4):438-42. PubMed ID: 2863107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predicting fetal perchlorate dose and inhibition of iodide kinetics during gestation: a physiologically-based pharmacokinetic analysis of perchlorate and iodide kinetics in the rat.
    Clewell RA; Merrill EA; Yu KO; Mahle DA; Sterner TR; Mattie DR; Robinson PJ; Fisher JW; Gearhart JM
    Toxicol Sci; 2003 Jun; 73(2):235-55. PubMed ID: 12700398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Physiologically based pharmacokinetic models in developmental toxicology.
    O'Flaherty EJ
    Risk Anal; 1994 Aug; 14(4):605-11. PubMed ID: 7972961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of intravenous theophylline in pregnant patients at term.
    Romero R; Kadar N; Gonzales Govea F; Hobbins JC
    Am J Perinatol; 1983 Oct; 1(1):31-5. PubMed ID: 6680648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Theophylline Pharmacokinetics in Foetal Sheep: Maternal Metabolic Capacity is the Principal Driver.
    DuBois B; Louey S; Giraud GD; Cherala G; Jonker SS
    Basic Clin Pharmacol Toxicol; 2015 Oct; 117(4):226-33. PubMed ID: 25728792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Physiologically based pharmacokinetic model of midazolam disposition during pregnancy.
    Andrew MA; Hebert MF; Vicini P
    Annu Int Conf IEEE Eng Med Biol Soc; 2008; 2008():5454-7. PubMed ID: 19163951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.